- Home
- MTUS vs AUTL Comparison
MTUS vs AUTL Comparison
Compare MTUS & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTUS
- AUTL
- Stock Information
- Founded
- MTUS 1899
- AUTL 2014
- Country
- MTUS United States
- AUTL United Kingdom
- Employees
- MTUS N/A
- AUTL N/A
- Industry
- MTUS
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTUS
- AUTL Health Care
- Exchange
- MTUS NYSE
- AUTL Nasdaq
- Market Cap
- MTUS 546.3M
- AUTL 625.4M
- IPO Year
- MTUS N/A
- AUTL 2018
- Fundamental
- Price
- MTUS $14.31
- AUTL $2.05
- Analyst Decision
- MTUS
- AUTL Strong Buy
- Analyst Count
- MTUS 0
- AUTL 5
- Target Price
- MTUS N/A
- AUTL $9.32
- AVG Volume (30 Days)
- MTUS 462.3K
- AUTL 2.4M
- Earning Date
- MTUS 08-07-2025
- AUTL 08-07-2025
- Dividend Yield
- MTUS N/A
- AUTL N/A
- EPS Growth
- MTUS N/A
- AUTL N/A
- EPS
- MTUS N/A
- AUTL N/A
- Revenue
- MTUS $1,042,900,000.00
- AUTL $9,011,000.00
- Revenue This Year
- MTUS $8.76
- AUTL $461.76
- Revenue Next Year
- MTUS $8.74
- AUTL $112.66
- P/E Ratio
- MTUS N/A
- AUTL N/A
- Revenue Growth
- MTUS N/A
- AUTL N/A
- 52 Week Low
- MTUS $10.78
- AUTL $1.11
- 52 Week High
- MTUS $23.26
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- MTUS 58.03
- AUTL 59.29
- Support Level
- MTUS $13.84
- AUTL $1.98
- Resistance Level
- MTUS $14.81
- AUTL $2.10
- Average True Range (ATR)
- MTUS 0.47
- AUTL 0.15
- MACD
- MTUS 0.03
- AUTL -0.03
- Stochastic Oscillator
- MTUS 67.75
- AUTL 44.53
About MTUS METALLUS INC
Metallus Inc is an America-based manufacturer of alloy steel, as well as carbon and micro-alloy steel. The portfolio of the company includes special bar quality steel, seamless mechanical tubes, and value-add solutions, such as precision steel components. The company also supplies machining and thermal treatment services and manages raw material recycling programs that work as a feeder system for its melt operations. The company's products and services are used in the following sectors: oil and gas; automotive; industrial equipment; mining; construction; rail; aerospace and defense; heavy truck; agriculture and power generation. Geographically, the company mainly serves customers in the United States.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.